Twenty-nine people in the US have developed anaphylaxis after being vaccinated against COVID-19 since the vaccine rollout began, health officials have reported, with...Coronavirus
Brazil has resumed the trials of a Chinese COVID-19 vaccine after halting them on two days earlier over a mysterious death. The reported ‘severe adverse event’ was...
November 11th, 2020Nearly a year has passed since SARS-CoV-2 began its deadly sweep across the world. This week, as global infections soared to more than 50 million and deaths to 1.25...
The pharmaceutical company AstraZeneca has announced that it has resumed its coronavirus vaccine trial in the UK after suspending it six days ago over potential safety...Weekly Roundup
It's dog eat dog in the world of COVID-19 vaccines. Reuters Health reports that that's the fear of global health agencies planning a scheme to bulk-buy and equitably...
July 22nd, 2020The candidate coronavirus vaccine AZD1222, being developed by University of Oxford and AstraZeneca, generated an immune response in a study of roughly 1,000...
Sinovac Biotech has announced preliminary study results showing its experimental COVID-19 vaccine generated immune responses in patients and was safe – early data that...Coronavirus
Volunteers who received Moderna's COVID-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health...Coronavirus
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a...
April 1st, 2020
Tuberculosis (TB) and HIV pose a significant burden on South Africa’s health system. And now there's the coronavirus.
There’s a close relationship between the TB...
